OverviewChartNewsTraderScreen

JP Morgan Put 300 AMGN 21.06.2024/  DE000JB9KRS3  /

EUWAX
2024-05-02  1:59:41 PM Chg.-0.08 Bid5:28:18 PM Ask5:28:18 PM Underlying Strike price Expiration date Option type
2.42EUR -3.20% 2.58
Bid Size: 50,000		 2.59
Ask Size: 50,000		 Amgen Inc 300.00 USD 2024-06-21 Put
TeleTrader 3:31 PM US opens higher, Dow jumps 240 points
GlobeNewswire 1:00 PM Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Canc...
TeleTrader 10:28 AM US higher premarket after Fed's decision
GlobeNewswire 05-01 Fight Colorectal Cancer Launches ChatCRC: An AI-Powered Chatbot Revolutionizing Colorectal Cancer Su...
GlobeNewswire 05-01 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire 04-30 Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab bios...
GlobeNewswire 04-24 Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeti...
TeleTrader 04-24 Wall Street opens mostly higher amid earnings jitters
GlobeNewswire 04-23 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...
GlobeNewswire 04-16 Turnstone Biologics Appoints William Waddill to its Board of Directors
GlobeNewswire 04-15 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
GlobeNewswire 04-15 Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer
GlobeNewswire 04-15 Shah Capital nominates two highly qualified independent director candidates for Novavax
GlobeNewswire 04-11 FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer
GlobeNewswire 04-09 Opthea Appoints John Han, PharmD, as VP Medical Affairs
GlobeNewswire 04-08 Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual ...
GlobeNewswire 04-08 CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Dire...
GlobeNewswire 04-05 NeuroVigil, World’s Most Valuable Neurotech, Launches iBrain™ in US
GlobeNewswire 04-05 CORRECTION -- NeuroVigil, World’s Most Valuable Neurotech Company, Launches in US
GlobeNewswire 04-05 NeuroVigil, World’s Most Valuable Neurotech Company, Launches in US
GlobeNewswire 04-04 Over 52 Million Myeloma Warriors Reached, Creating Ripples Across the Globe for #MyelomaACTIONMonth
GlobeNewswire 04-03 CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engag...
GlobeNewswire 04-02 ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer
GlobeNewswire 03-28 Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
TeleTrader 03-26 US opens higher on data, Trump Media launch